List of bibliographic references
Number of relevant bibliographic references: 41.
[0-20] [
0 - 20][
0 - 41][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000074 (2000) |
R. Grondin [Canada] ; A. Hadj Tahar ; V D Doan ; P. Ladure ; P J Bédard | Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys. |
| 000106 (2000) |
S. Callier [Canada] ; M. Morissette ; M. Grandbois ; T. Di Paolo | Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice. |
| 000337 (1992) |
B. Gomez-Mancilla [Canada] ; P J Bédard | Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys. |
| 000366 (2003) |
Patrick L. Mcgeer [Canada] ; Claudia Schwab ; Andre Parent ; Doris Doudet | Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. |
| 000502 (1992) |
W G Tatton [Canada] ; C E Greenwood ; N A Seniuk ; P T Salo | Interactions between MPTP-induced and age-related neuronal death in a murine model of Parkinson's disease. |
| 000519 (2005) |
Raymond H. Kim [Canada] ; Patrice D. Smith [Canada] ; Hossein Aleyasin [Canada] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Scott Pownall [Canada] ; Andrew Wakeham [Canada] ; Annick J. You-Ten [Canada] ; Suneil K. Kalia [Canada] ; Patrick Horne [Canada] ; David Westaway [Canada] ; Andres M. Lozano [Canada] ; Hymie Anisman [Canada] ; David S. Park [Canada] ; Tak W. Mak [Canada] | Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress |
| 000570 (2005) |
Anne M. Landau [Canada] ; Kelvin C. Luk [Canada] ; Michelle-Lee Jones [Canada] ; Rosmarie Siegrist-Johnstone [Canada] ; Yoon Kow Young [Canada] ; Edouard Kouassi ; Vladimir V. Rymar [Canada] ; Alain Dagher [Canada] ; Abbas F. Sadikot [Canada] ; Julie Desbarats [Canada] | Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease |
| 000596 (2006) |
J. Miklossy [Canada] ; D D Doudet ; C. Schwab ; S. Yu ; E G Mcgeer ; P L Mcgeer | Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. |
| 000657 (1991) |
B. Gomez-Mancilla [Canada] ; P J Bédard | Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. |
| 000785 (2007) |
Dianbo Qu [Canada] ; Juliet Rashidian ; Matthew P. Mount ; Hossein Aleyasin ; Mohammad Parsanejad ; Arman Lira ; Emdadul Haque ; Yi Zhang ; Steve Callaghan ; Mireille Daigle ; Maxime W C. Rousseaux ; Ruth S. Slack ; Paul R. Albert ; Inez Vincent ; John M. Woulfe ; David S. Park | Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. |
| 000833 (2007) |
Christopher A. Shaw ; Günter U. Höglinger | Neurodegenerative Diseases: Neurotoxins as Sufficient Etiologic Agents? |
| 000991 (1991) |
O S Kofman [Canada] | Deprenyl: protective vs. symptomatic effect. |
| 000A71 (2009) |
Dirk W. Luchtman [Canada] ; Di Shao ; Cai Song | Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease. |
| 000C12 (2010) |
Bazoumana Ouattara [Canada] ; Fabrizio Gasparini ; Marc Morissette ; Laurent Grégoire ; Pershia Samadi ; Baltazar Gomez-Mancilla ; Thérèse Di Paolo | Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys. |
| 000C30 (2010) |
Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Mcildowie ; Matthew J. Piggott ; Jonathan M. Brotchie | Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
| 000C42 (1991) |
J C Furtado [Canada] ; M F Mazurek | MPTP-induced neurotoxicity and the quest for a preventative therapy for Parkinson's disease. |
| 000D46 (2010) |
Susan H. Fox [Canada] ; Jonathan M. Brotchie | The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. |
| 000F02 (2011) |
Arman Lira ; Jerzy Kulczycki ; Ruth Slack ; Hymie Anisman ; David S. Park | Involvement of the Fcγ Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss* |
| 000F27 (2011) |
Philippe Huot [Canada] ; Susan H. Fox ; Adrian Newman-Tancredi ; Jonathan M. Brotchie | Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism? |
| 000F62 (1990) |
R T Ross [Canada] | Drug-induced parkinsonism and other movement disorders. |
| 000F85 (2011) |
Boris Rosin [Israël] ; Maya Slovik ; Rea Mitelman ; Michal Rivlin-Etzion ; Suzanne N. Haber ; Zvi Israel ; Eilon Vaadia ; Hagai Bergman | Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "MPTP Poisoning"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i \
-Sk "MPTP Poisoning" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= Mesh.i
|clé= MPTP Poisoning
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
